IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 221 filers reported holding IVERIC BIO INC in Q3 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,989,941 | +81.5% | 101,422 | +12.3% | 0.04% | +84.2% |
| Q1 2023 | $2,197,924 | +13.0% | 90,338 | -0.6% | 0.02% | +11.8% |
| Q4 2022 | $1,944,884 | +68.1% | 90,840 | +40.8% | 0.02% | +54.5% |
| Q3 2022 | $1,157,000 | +74.2% | 64,495 | -6.6% | 0.01% | +83.3% |
| Q2 2022 | $664,000 | -66.8% | 69,057 | -41.9% | 0.01% | -72.7% |
| Q1 2022 | $2,001,000 | -9.8% | 118,869 | -10.4% | 0.02% | -12.0% |
| Q4 2021 | $2,218,000 | +7.1% | 132,675 | +4.1% | 0.02% | +25.0% |
| Q3 2021 | $2,070,000 | +176.0% | 127,476 | +7.2% | 0.02% | +185.7% |
| Q2 2021 | $750,000 | -25.6% | 118,878 | -27.1% | 0.01% | -30.0% |
| Q1 2021 | $1,008,000 | -9.8% | 163,089 | +0.8% | 0.01% | -23.1% |
| Q4 2020 | $1,118,000 | +73.6% | 161,774 | +41.7% | 0.01% | +44.4% |
| Q3 2020 | $644,000 | +84.0% | 114,139 | +66.5% | 0.01% | +80.0% |
| Q2 2020 | $350,000 | – | 68,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |